MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Clinical correlates of depression and anxiety in patients with Parkinson’s disease

    H.D. Hambardzumyan, H.M. Manvelyan (Yerevan, Armenia)

    Objective: To clarify whether depression and anxiety are similar in terms of their associations with other clinical variables. Background: Although depression and anxiety are important…
  • 2016 International Congress

    Validation study of Parkinson anxiety scale, Czech version

    N. Zemanová, M. Baláz (Brno, Czech Republic)

    Objective: The study aims to evaluate psychometric properties of Czech version of Parkinson Anxiety Scale (PAS), new scale developed in 2014 to measure anxiety specifically…
  • 2016 International Congress

    The National Parkinson Foundation mentoring and networking program: Phase I the process

    C.B. Hunter, P.R. Palmentera, B. Vernon, A. Silver, K. Arney, J. Fleisher, F. Cubillos (Houston, TX, USA)

    Objective: The National Parkinson Foundation (NPF) has focused on meeting the needs in the care and treatment of Parkinson's disease (PD). Through the Centers of…
  • 2016 International Congress

    The relationship between body composition and postural instability in idiopathic Parkinson’s disease

    K.S. Diab, L.A. Hale, D.L. Waters, M.A. Skinner, G. Hammond-Took (Baghdad, Iraq)

    Objective: There appears to be no research that has focused on the relationship between body composition phenotype and postural instability in IPD. The aim of…
  • 2016 International Congress

    Predicting poor functional outcome in Parkinson’s disease

    A.D. Macleod, C.E. Counsell (Aberdeen, United Kingdom)

    Objective: We aimed to describe progression to, identify independent prognostic factors for, and develop a valid prognostic model for, dependency and “death or dependency” in…
  • 2016 International Congress

    Motor symptoms in patients with early stages of Parkinson’s disease

    E.N. Gubanova, N.V. Fedorova (Moscow, Russia)

    Objective: To determine the range of motor symptoms in PD patients on early stages and their the influence on quality of life and daily activities.…
  • 2016 International Congress

    Quality of life and living with Parkinson’s in Ireland

    I. Cassidy, P. Meskell, M.P. Butler, M. Richardson, C. Kennedy, S. Coote, P. Boers (Limerick, Ireland)

    Objective: (1) Assess the quality of life (QoL) for people with Parkinson's and explore associations between (QoL) and demographics (2) Investigate incidence of depression and…
  • 2016 International Congress

    The method of biofeedback training for the patients with Parkinson’s disease

    I.S. Goursky, S.A. Likhachev, V.V. Vashchylin (Minsk, Belarus)

    Objective: The objective of the research was to develop a biofeedback training method for the patients with Parkinson's disease (PD), utilizing videomotion analysis for the…
  • 2016 International Congress

    Inflammatory profile discriminates clinical subtypes in LRRK2-associated PD

    K. Brockmann, C. Schulte, N. Schneiderhan-Marra, A. Apel, C. Pont-Sunyer, D. Vilas, J. Ruiz-Martinez, M. Langkamp, J.C. Corvol, F. Cormier, T. Knorpp, T.O. Joos, A. Bernhard, T. Gasser, C. Marras, B. Schüle, J.O. Aasly, T. Foroud, J.F. Marti-Masso, A. Brice, E. Tolosa, D. Berg, W. Maetzler (Tübingen, Germany)

    Objective: To evaluate whether inflammatory processes in PD patients with mutations in the LRRK2 gene (PD-LRRK2) are associated with modification of clinical features and disease…
  • 2016 International Congress

    Do mutations in the TGM6 (SCA35) gene cause early-onset Parkinson’s disease?

    A. Westenberger, M. Svetel, N. Dragaševic, I. Brænne, V. Dobricic, A.A. Hicks, A. Tomic, N. Kresojevic, H. Pawlack, K. Grütz, A. Domingo, J. Erdmann, V.S. Kostic, C. Klein (Luebeck, Germany)

    Objective: To identify the genetic cause of early-onset Parkinson's disease (EOPD) in a Serbian family. Background: Hereditary EOPD is a genetically heterogeneous neurodegenerative disorder, characterized…
  • « Previous Page
  • 1
  • …
  • 341
  • 342
  • 343
  • 344
  • 345
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley